OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma
Kristina Breitenecker, Viola Hedrich, Franziska Pupp, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Kristina Breitenecker, Viola Hedrich, Franziska Pupp, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Showing 4 citing articles:
Therapeutic advances of targeting receptor tyrosine kinases in cancer
Ciprian Tomuleasa, Adrian Bogdan Țigu, Raluca Munteanu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 25
Ciprian Tomuleasa, Adrian Bogdan Țigu, Raluca Munteanu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 25
Sorafenib resistance and therapeutic strategies in hepatocellular carcinoma
Weijing Zhang, Xuechuan Hong, Yuling Xiao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189310-189310
Closed Access | Times Cited: 2
Weijing Zhang, Xuechuan Hong, Yuling Xiao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189310-189310
Closed Access | Times Cited: 2
GAS6/TAM Axis as Therapeutic Target in Liver Diseases
Anna Tutusaus, Albert Morales, Pablo Garcı́a de Frutos, et al.
Seminars in Liver Disease (2024) Vol. 44, Iss. 01, pp. 099-114
Open Access | Times Cited: 2
Anna Tutusaus, Albert Morales, Pablo Garcı́a de Frutos, et al.
Seminars in Liver Disease (2024) Vol. 44, Iss. 01, pp. 099-114
Open Access | Times Cited: 2
Resistance to Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma (HCC): Clinical Implications and Potential Strategies to Overcome the Resistance
Ali Gawi Ermi, Devanand Sarkar
Cancers (2024) Vol. 16, Iss. 23, pp. 3944-3944
Open Access
Ali Gawi Ermi, Devanand Sarkar
Cancers (2024) Vol. 16, Iss. 23, pp. 3944-3944
Open Access
